tirzepatide cardiovascular trial 💡 New insight in diabetes care: In patients with T2DM and ASCVD, the SURPASS-CVOT found that was noninferior to dulaglutide for major events (12.2% vs 13.1%; HR 0.92). What Cardiovascular Outcomes with Tirzepatide versus

Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society. American Journal of Lifestyle Medicine , 30 May 2025, Locatelli, Joo Carlos, et al

The implications rippled through the entire grey-market peptide community

While others rushed to assist, Health and Human Services Secretary Robert Kennedy Jr

Alongside its cousin, the mexican beaded lizard, it belongs to the helodermatidae genus

Free carnitine, total carnitine, and total acylcarnitine profile Despite daily thyroid hormone replacement therapy, the congenital hypothyroid patients had been suffering from persistent fatigue